Stockscreener 앱 받기
18.95
3.71%
-0.73
시간 외 거래:
18.72
-0.23
-1.21%
전일 마감가:
$19.68
열려 있는:
$19.97
하루 거래량:
944.61K
Relative Volume:
1.44
시가총액:
$514.58M
수익:
$157.75M
순이익/손실:
$-29.73M
주가수익비율:
-16.34
EPS:
-1.16
순현금흐름:
$-21.00M
1주 성능:
-16.00%
1개월 성능:
+5.34%
6개월 성능:
+102.67%
1년 성능:
-8.05%
1일 변동 폭
$18.37
$20.25
1주일 범위
$18.37
$22.92
52주 변동 폭
$8.04
$23.59
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
명칭
Arcturus Therapeutics Holdings Inc
전화
(858) 900-2660
주소
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
ARCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
18.95 | 534.40M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-05-28 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-28 | 개시 | BTIG Research | Buy |
| 2024-08-12 | 개시 | Leerink Partners | Outperform |
| 2023-12-13 | 개시 | Canaccord Genuity | Buy |
| 2023-07-24 | 개시 | William Blair | Outperform |
| 2023-05-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | 재개 | Wells Fargo | Overweight |
| 2022-11-10 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-11-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-08-10 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | 재개 | Cantor Fitzgerald | Overweight |
| 2022-05-11 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-01-31 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-10 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2021-06-21 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-02-17 | 다운그레이드 | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | 개시 | Wells Fargo | Overweight |
| 2020-12-29 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | 다운그레이드 | ROTH Capital | Buy → Sell |
| 2020-12-08 | 재확인 | B. Riley Securities | Buy |
| 2020-12-07 | 재확인 | B. Riley Securities | Buy |
| 2020-10-26 | 개시 | Barclays | Overweight |
| 2020-10-06 | 개시 | Citigroup | Buy |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-07-30 | 재개 | ROTH Capital | Buy |
| 2020-07-16 | 개시 | Raymond James | Outperform |
| 2020-07-13 | 개시 | B. Riley FBR | Buy |
| 2020-06-09 | 다운그레이드 | WBB Securities | Buy → Hold |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2020-02-07 | 개시 | Guggenheim | Buy |
| 2020-02-06 | 개시 | Guggenheim | Buy |
| 2019-04-05 | 개시 | H.C. Wainwright | Buy |
| 2018-09-20 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | 개시 | Chardan Capital Markets | Buy |
모두보기
Arcturus Therapeutics Holdings Inc 주식(ARCT)의 최신 뉴스
What MACD and RSI say about Arcturus Therapeutics Holdings Inc.Fed Meeting & Weekly Momentum Picks - newser.com
Technical analysis overview for Arcturus Therapeutics Holdings Inc. stockJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Using data models to predict Arcturus Therapeutics Holdings Inc. stock movementEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
Arcturus Therapeutics (ARCT) Anticipated to Benefit from Upcoming Data Release - GuruFocus
Published on: 2025-10-10 03:52:17 - newser.com
Applying chart zones and confluence areas to Arcturus Therapeutics Holdings Inc.2025 Market Overview & Verified High Yield Trade Plans - newser.com
Arcturus Therapeutics (NASDAQ:ARCT) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
How to use Fibonacci retracement on Arcturus Therapeutics Holdings Inc.Quarterly Performance Summary & Technical Pattern Based Signals - newser.com
Is this a good reentry point in Arcturus Therapeutics Holdings Inc.July 2025 Selloffs & Free High Return Stock Watch Alerts - newser.com
Arcturus Stock Rockets From $9 To $18 In 5 MonthsAll Eyes On Upcoming Cystic Fibrosis Data - RTTNews
Published on: 2025-10-09 02:58:21 - newser.com
Is Arcturus Therapeutics Holdings Inc a good long term investmentChart Pattern Recognition & Double Or Triple Investment - earlytimes.in
Arcturus Therapeutics Holdings Inc Stock Analysis and ForecastBollinger Bands Signals & Investor Community Interactions - earlytimes.in
Public Employees Retirement System of Ohio Makes New Investment in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 4.7%Should You Sell? - MarketBeat
What high frequency data says about Arcturus Therapeutics Holdings Inc.Quarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Real time social sentiment graph for Arcturus Therapeutics Holdings Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Does Arcturus Therapeutics Holdings Inc. fit your quant trading modelTrade Risk Summary & Long-Term Capital Growth Ideas - newser.com
Arcturus Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
What dividend safety score for Arcturus Therapeutics Holdings Inc. stockJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
Best data tools to analyze Arcturus Therapeutics Holdings Inc. stockJuly 2025 Summary & Verified Technical Signals - newser.com
Arcturus Therapeutics (NASDAQ:ARCT) Shares Gap UpHere's What Happened - MarketBeat
High Growth Tech Stocks In The US For September 2025 - simplywall.st
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 9.7%Here's What Happened - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
How to recover losses in Arcturus Therapeutics Holdings Inc. stock2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
What drives Arcturus Therapeutics Holdings Inc stock priceCapital Gains Strategies & Small Capital Trading Plans - earlytimes.in
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 7.4%Should You Buy? - MarketBeat
Visualizing Arcturus Therapeutics Holdings Inc. stock with heatmapsPortfolio Value Summary & Low Volatility Stock Suggestions - newser.com
Cathie Wood Just Dumped $3.5 Million in Roku and Roblox For This Hot Stock - parameter.io
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock - Investing.com
Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft - Law360
ARK Investment Expands Stake with Purchase in Arcturus Therapeutics (ARCT) - GuruFocus
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating - Seeking Alpha
Arcturus Therapeutics Holdings Inc (ARCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):